Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record for the completed DUO Phase 3 trial is displayed, including its treatments, eligibility criteria, study locations, outcomes, and linked study documents.
    Difference
    72%
    Check dated 2026-11-08T12:35:21.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T13:34:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:00:06.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:20:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:50:02.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a visible 403 label and a Home button, indicating that access to the page is blocked. This reflects an access-control state change rather than updates to the page's substantive content.
    Difference
    0.5%
    Check dated 2026-09-27T20:00:28.000Z thumbnail image

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.